Adagio Medical, an innovator in catheter ablation technologies for treatment of cardiac arrhythmias, agreed to go public via a SPAC merger with ARYA Sciences Acquisition, a special purpose acquisition company. Financial terms were not disclosed. "The business combination agreement and Adagio Medical's evolution to a public company is a natural next step in our relationship with Perceptive Advisors and other investor groups who have long supported Adagio Medical's innovations aimed to improve the efficacy of cardiac ablations," Olav Bergheim, Adagio Medical President and CEO.